Skip to content

The ATtune Knee Outcome Study

The ATtune Knee Outcome Study: Prospective Evaluation of a Novel Uncemented Rotating Platform Total Knee Arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04247672
Acronym
ATKOS
Enrollment
900
Registered
2020-01-30
Start date
2020-02-03
Completion date
2036-01-22
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis, Knee Rheumatism, Osteoarthritis, Knee, Rheumatoid Arthritis

Brief summary

To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.

Detailed description

Every year, 1.5 million total knee arthroplasties (TKA) are performed worldwide in patients whose joints have been severely affected by osteoarthritis, rheumatoid arthritis, or trauma, causing intense pain and loss of function. Due to the ageing society, these numbers are expected to have increased six-fold to 3.48 million cases annually by 2030. Even though joint replacement provides satisfactory and durable results for most patients, 20% is thought to still not be satisfied with their artificial joint. To accommodate this dissatisfied population and improve durability of implants even more, several knee systems have been developed over the years. One of the newest models is the ATTUNE knee system (DePuy, Warsaw, Indiana, USA). One of the landmark features is a gradually reducing radius in the geometry of the femoral component, more closely mimicking the anatomical patellofemoral joint and facilitating more natural femoral rollback during flexion. Comparisons of the cemented ATTUNE with previous knee systems show promising results in terms of patellofemoral outcomes, but fail to demonstrate definitive superiority in terms of all patient reported outcomes. Clinical superiority of the ATTUNE tends to abate with longer follow-up, implicating a possible superiority in the short-term recovery and return to activities. There is no follow-up study reporting the results of the uncemented ATTUNE. Moreover, all previously cited studies report better patellofemoral outcomes with patellar resurfacing, making it still unclear whether the implicated superior design changes of the femoral component hold ground without patellar resurfacing. The primary objective is to report survivorship, complications and patient reported outcome measures associated with the uncemented ATTUNE rotating platform knee system. Secondary objectives are (1) evaluate patient reported (patellofemoral) outcomes (2) assess return to work and sport after TKA (3) translate and validate the Dutch version of the University of California, Los Angeles (UCLA) activity scale and (4) analyse psychologic factors (such as pain catastrophising and coping) and the impact on dissatisfaction following TKA.

Interventions

DEVICETotal Knee Arthroplasty (uncemented rotating platform ATTUNE)

All patients receive an uncemented ATTUNE rotating platform knee system.

Sponsors

Spaarne Gasthuis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years

Inclusion criteria

* End-stage osteoarthritis of the knee warranting joint replacement therapy. * Indicated for an ATTUNE total knee system as part of regular clinical practice. * Capability and willingness to sign informed consent and comply with follow-up procedures. * Capable enough in Dutch or English to be able to understand study procedures

Exclusion criteria

* Unable or unwilling to sign informed consent and comply with follow-up * Indication for primary revision arthroplasty * Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)

Design outcomes

Primary

MeasureTime frameDescription
Survivorship10 yearCalculated by determining revision rate. Septic, aseptic and all-cause revision rates will be calculated seperately.
Complication rate10 yearAll substantial complications associated with total knee arthroplasty will be registered and reported
Forgotten Joint Score 12 (FJS-12)10 year
Kujala Anterior Knee Pain Scale (AKPS)10 year
Knee injury and Osteoarthritis Outcome Scale - Physical Function Short Form10 yearKOOS-PS
Numeric Rating Scale (NRS)10 yearNRS on pain and satisfaction
EuroQol 5 Dimensions, 3 Levels (EQ5D-3L)10 year

Secondary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-2)10 year2-item questionnaire to screen for major depressive episodes
30 second chair stand test (30sCST)1 yearThe amount of times one can stand up and sit down from a chair in 30 seconds
Pain Catastrophizing Scale (PCS)10 yearExplores pain catastrophizing and its relation to pain behaviour
Pain Self Efficacy Questionnaire (PSEQ)10 yearQuestionnaire to asses pain self efficacy
40m Fast paced walk test (40m-FPWT)1 yearThe amount of seconds one does to walk 40 meters.
Stair climb test (SCT)1 yearThe time one takes to walk a set of stairs up and down.
Tegner activity rating scale1 year1-item questionnaire
University of California, Los Angeles (UCLA) activity rating scale1 year1-item questionnaire
Return to work1 yearAssessed by a short self-composed questionnaire, which evaluates what kind of work the patients do, when they started after surgery and whether this is the same as their preoperative job
Alignment1 yearA long-leg radiograph is performed 1 year after surgery to assess mechanical alignment of the prosthesis with consideration of femur and tibia

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026